4th Department of Surgery, General Hospital "George Papanikolaou", Aristotle University of Thessaloniki, 57010 Exochi, Greece.
Pathology Department, Faculty of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Biomolecules. 2024 Jul 29;14(8):921. doi: 10.3390/biom14080921.
Mesh-augmented hernia repair is the gold standard in abdominal wall and hiatal/diaphragmatic hernia management and ranks among the most common procedures performed by general surgeons. However, it is associated with a series of drawbacks, including recurrence, mesh infection, and adhesion formation. To address these weaknesses, numerous biomaterials have been investigated for mesh coating. Platelet-rich plasma (PRP) is an autologous agent that promotes tissue healing through numerous cytokines and growth factors. In addition, many reports highlight its contribution to better integration of different types of coated meshes, compared to conventional uncoated meshes. The use of PRP-coated meshes for hernia repair has been reported in the literature, but a review of technical aspects and outcomes is missing. The aim of this comprehensive review is to report the experimental studies investigating the synergistic use of PRP and mesh implants in hernia animal models. A comprehensive literature search was conducted across PubMed/Medline, Web of Science, and Scopus without chronological constraints. In total, fourteen experimental and three clinical studies have been included. Among experimental trials, synthetic, biologic, and composite meshes were used in four, nine, and one study, respectively. In synthetic meshes, PRP-coating leads to increased antioxidant levels and collaged deposition, reduced oxidative stress, and improved inflammatory response, while studies on biological meshes revealed increased neovascularization and tissue integration, reduced inflammation, adhesion severity, and mechanical failure rates. Finally, PRP-coating of composite meshes results in reduced adhesions and improved mechanical strength. Despite the abundance of preclinical data, there is a scarcity of clinical studies, mainly due to the absence of an established protocol regarding PRP preparation and application. To this point in time, PRP has been used as a coating agent for the repair of abdominal and diaphragmatic hernias, as well as for mesh fixation. Clinical application of conclusions drawn from experimental studies may lead to improved results in hernia repair.
网片增强疝修补术是腹壁和食管裂孔/横膈疝管理的金标准,也是普通外科医生最常进行的手术之一。然而,它也存在一系列缺点,包括复发、网片感染和粘连形成。为了解决这些问题,已经研究了许多生物材料来进行网片涂层。富含血小板的血浆 (PRP) 是一种自体制剂,通过多种细胞因子和生长因子促进组织愈合。此外,许多报道强调了它在改善不同类型涂层网片的整合方面的作用,与传统的未涂层网片相比。文献中已经报道了 PRP 涂层网片在疝修补中的应用,但缺乏对技术方面和结果的综述。本综述的目的是报告关于 PRP 和网片植入物在疝动物模型中协同应用的实验研究。在没有时间限制的情况下,我们在 PubMed/Medline、Web of Science 和 Scopus 上进行了全面的文献检索。共纳入了 14 项实验研究和 3 项临床研究。在实验性试验中,合成、生物和复合网片分别在 4、9 和 1 项研究中使用。在合成网片中,PRP 涂层可提高抗氧化水平和胶原沉积,降低氧化应激,改善炎症反应,而在生物网片研究中,发现可增加新生血管和组织整合,减少炎症、粘连严重程度和机械失败率。最后,PRP 涂层的复合网片可减少粘连并提高机械强度。尽管有大量的临床前数据,但临床研究却很少,主要是因为缺乏关于 PRP 制备和应用的既定方案。到目前为止,PRP 已被用作修复腹壁和横膈疝以及固定网片的涂层剂。从实验研究中得出的结论的临床应用可能会导致疝修补术的结果得到改善。